共 17 条
- [1] IL-12–Based Vaccination Therapy Reverses Liver-Induced Systemic Tolerance in a Mouse Model of Hepatitis B Virus Carrier[J] . Zhutian Zeng,Xiaohui Kong,Fenglei Li,Haiming Wei,Rui Sun,Zhigang Tian.  The Journal of Immunology . 2013 (8)
- [3] Interleukin-21 responses in patients with chronic hepatitis B. Suri H,Ren W,Ma W,et al. Journal of Interferon and Cytokine Research . 2014
- [4] IL-21 restricts virusdriven Treg cell expansion in chronic LCMV infection. Schmitz I,Schneider C,Frhlich A,et al. PLoSOne . 2013
- [5] Mycobacterium tuberculosis-Specific IL-21+IFN-[gamma]+CD4+T Cells Are Regulated by IL-12. Li L,Jiang Y,Lao S,et al. Plo S one . 2016
- [6] IL-21R gene polymorphisms and serum\sIL-21 levels predict virological response to interferon-based therapy in\sAsian chronic hepatitis C patients. Hsu CS,Hsu SJ,Liu WL,et al. Antiviral Therapy . 2013
- [7] High serum IL-21 levels after 12<ce:hsp sp="0.25"/>weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B[J] . Shi-Wu Ma,Xuan Huang,Yong-Yin Li,Li-Bo Tang,Xiao-Feng Sun,Xiao-Tao Jiang,Yue-Xin Zhang,Jian Sun,Zhi-Hua Liu,William G.H. Abbott,Yu-Hong Dong,Nikolai V. Naoumov,Jin-Lin Hou.  Journal of Hepatology . 2011 (4)
- [8] Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection[J] . Bo Yang,Yadong Wang,Caiyan Zhao,Wenzhao Yan,Honghao Che,Chuan Shen,Meng Zhao.  Immunology Letters . 2012